Trade IMA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ImageneBio, Inc. (IMA) is trading at US$4.25, up 0.24% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$62.55M. Over the past 52 weeks, IMA has traded between US$3.90 and US$9.10. On Syfe you can trade IMA with $0 commission and add it to your watchlist.
| Previous close | US$4.24 |
|---|---|
| Market cap | US$62.55M |
| 52-week range | US$3.90 – US$9.10 |
| Volume | 28.05K |
| Exchange | US |
ImageneBio, Inc.
ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.
Year: 2025
--HC Wainwright Initiates ImageneBio at Buy With $28 Price Target
Aug 21, 10:36 AM · MT Newswires
ImageneBio, Inc. (IMA) stock is trading at US$4.25, +0.24% from the previous close of US$4.24.
The market cap for ImageneBio, Inc. (IMA) stock is approximately US$62.55M.
The 52-week high for ImageneBio, Inc. (IMA) stock is US$9.10.
The 52-week low for ImageneBio, Inc. (IMA) stock is US$3.90.
ImageneBio, Inc. (IMA) does not currently pay a dividend.
Stay on top of IMA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
